Epidemiologic profile of gastric carcinoma: Study of 140 cases;Profil épidémiologique de l'adénocarcinome gastrique: Étude de 140 cas

Tunisie Medicale

Volumn 84, Issue 5, 2006, Pages 301-304

  Arfaoui, Dalenda ^a   Elloumi, Hela ^a   Hamila, Felimi ^a   Gouma, Mouna ^a   Ben Abdellaziz, Ahmed ^b,c   Star, Souhir ^a   Imaa, Ali ^a   Gannem, Hassen ^b,c   Bel Hadj Hmida, Ridha ^a   Ajmi, Salem ^a  

^a SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

^b Service d'Épidémiologie   (Tunisia)

^c FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Adenocarcinoma; Epidemiology; Stomach; Surgery

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CONTROLLED STUDY; EPIDEMIOLOGY; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; STOMACH CARCINOMA; SURVIVAL RATE; AGED; CANCER STAGING; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICS; STOMACH TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE; TUNISIA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUNISIA;

EID: 33747040782     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Perrot L, Champault G. Quoi de neuf dans le cancer de l'estomac? J Chir. 1998; 135: 148-54
2. 2-Yu W, Choi GS, Whang I, Sun IS. Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg 1997; 84: 1305-9
3. Iradj S. Hélicobacter pylori et cancer gastrique. Med Sci 2003; 19: 431-6
4. MC Farlune GA, Munro A. Helicobacter pylori and gastric cancer. Br J Surg 1997; 84: 1190-9
5. Hundahl SA , Menck HR, Mansrir EG, Winchester DP. The national cancer data hase report on gastric carcinoma. Cancer 1997;80:2333-41
6. Ktamura K, Yamaguchi T, Sawai K et al. Chronologic changing in the clinicopathologic finding and survival gastric cancer patients. J clin oncol 1997;12:3471-80
7. Bouché O, Elias D, Legoux J L, Rougier Ph, Triboulet J P. Que faire devant un cancer digestif en 2003? Recommandations de la FFCD. Gastroenterol Clin Biol 2002; 26: 1140-64
8. Buker EC, Karpech MS, Conlon KC, Brenna MF. Laparoscopic in the management of gastric adenocarcinoma. Ann Surg 225:262-7.
9. Charles S F, Robert J M. Gastric carcinoma. N Engl J Med 1995; 333: 32-41
10. Elias D. Vers une standardisation des procédures chirurgicales et anatomopathologiques d'études des ganglions au cours des gastrectomies pour cancer. Hépato-Gastroenterology 1997; 48: 407-15
11. Liu K J M, Loewen M, Atten M J et al. The survival of stage III gastric cancer patients is affected by the number of lymph nodes removed. Surgery 2003; 134: 639-46
12. Deguili M, Sasoko M, Ponzetto A, Extension lymph node dissection for gastric cancer: result of prospective multi center analysis of morbidity and mortality in 118 consecutive cases. Eur J Surg Oncol 1997; 23: 310-14
13. Bostanci EB, Yol S, Kayaalp, C Ozogul Y, Aydin C, F Ataaly, M Akoglu. Comparison of complication of complication after D2 and D3 dissection for gastric cancer. J Cancer Surgery 2004; 30: 20-5.
14. Kitamura K, Yamaguchi T, Sawaik, Nishida S, Yamamoto K, Okomato K. Chronologic Changes in the clinicopatologic finding and survival of gastric cancer patients. J Clin Oncol 1997; 15: 3471-80.
15. Csendo A, Burdiles P, Rajas J, Brachetto I, Diaz JC, Maluenda F. A prospective randomised study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 malades with gastric carcinoma. Surgery 2002; 131: 401-7.
16. Sasako M. Risk factor for surgical treatement in the dutch gastric cancer trial. Br J Surg 1997; 84: 1567-71.
17. Roviello F, Marrelli D, Mangoni G, et al. Prospective study of peritonéal récurrence after curative surgery for gastric cancer. Br J Surg 2003; 90: 1113-9.
18. Lee C, Lo S, Wu C et al. Peritoneal reccurence of gastric adenocarcinoma after curative resection. Hepato-Gastroenterology 2003; 50: 1720-2
19. Mac Donald JS, Smalley SR. Benedettij et al. Chemoradiotherapy after suregery compared with surgery alone for adenocarcinoma of the stomach or gastrooesophageal junction. N Eng J Med 2001; 345: 725-30.
20. Msika S, Benhamiche A, Rat P, Fairure J. Pronostic à long terme du cancer gastrique dans la population de côte- d'or Gastroenterol Clin Biol 2000; 240: 649-55.
21. Allgayer H, Heiss MM, Schildberg F W. Review of pronostic factors in gastric cancer. Br J Surg 1997; 84: 1651-64.
22. Talamonti MS, Kim SP, Yao KA et al. Surgical outcomes of patients with gastric carcinoma: The importance of primary tumor location and microvessel invasion. Surgery 2003; 134: 720-9
23. Yokota T, Ishiyama S, Saito T et al. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol 2004; 39: 380-4
24. Sumiya I, Shoji N. Clinical importance of preoperative Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 levels in gastric cancer. J Clinic Gastroenterol 2001; 32: 41-4.
25. Wucc, Chen JT, Chang MC, et al. Optimal surgical strategy for potentially curable serosa involved gastric carcinoma with intra peritoneal free cells. J Am Coll Surg 1997; 184: 611-7.